COPENHAGEN/OSLO/STOCKHOLM (Reuters) – Denmark, Sweden and Norway said on Friday they needed more time to decide whether to use AstraZeneca’s COVID-19 vaccine even though the EU drug watchdog...

(Reuters Health) – The AstraZeneca COVID-19 vaccine developed with the University of Oxford has an efficacy of only 10.4% against the South African variant of the virus, according to data published...

(Reuters) – Canadian drug developer Medicago said on Tuesday it had started a late-stage study of its experimental COVID-19 vaccine combined with an adjuvant from GlaxoSmithKline. The study plans...

GENEVA/COPENHAGEN (Reuters) – The World Health Organization appealed to countries on Monday not to pause vaccination campaigns after two more European nations and one in Asia joined a handful which...

New pills to treat patients with COVID-19 are currently in midstage clinical trials and, if successful, could be ready by the end of the year. Only one treatment — remdesivir (Veklury) — has been fully...

ZURICH (Reuters) – Swiss drugmaker Roche said on Thursday adding its drug Actemra to Gilead Sciences’ Veklury medication, also called remdesivir, did not reduce hospital stays for patients...

NEW YORK (Reuters Health) – Children hospitalized with acute COVID-19 infection and multisystem inflammatory syndrome (MIS-C) may develop acute kidney injury, according to a new report. “In...

MADRID (Reuters) – The coronavirus lockdown has led to a plunge in the number of monthly births in Spain to the lowest recorded level ever, preliminary statistics showed on Wednesday, matching similar...

LONDON (Reuters) – Governments and airlines in Europe are hoping that vaccine certificates and digital health apps can help make travel for the masses a reality again this summer after a year of...

NEW YORK (Reuters Health) – Cats are highly susceptible to SARS-CoV-2, but transmissibility is reduced as the virus spreads through cats, according to new research from China. Studies have suggested...